CRISPR, gene therapy, CAR-T, and Covid vaccines. Science is advancing at a blistering pace.
But as STAT’s Matthew Herper explained in his Thursday story, “Biology’s Century,” we don’t always have the best possible evidence for what works and what does not.
“We’re embracing shortcuts called ‘real-world evidence’ in place of rigorous studies that randomize patients to receive one treatment or another,” Matt wrote. “Our electronic health records, a key to moving forward, are siloed and maddeningly unstructured. And we haven’t figured out how to deal with other biotechnologies that aim to change manufacturing, bring back extinct animals, or change how crops are grown.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect